Licensed, profitable German medical cannabis importer & wholesaler for sale on target for €8M/yr revenue
Fully licensed & profitable German medical cannabis distributor offers an integrated, EU-GDP compliant platform for immediate market access and a gateway to EU-GMP processing, on target for €8M revenue in 2025 with €10.8M projected in 2026
Listing ID:
42249812560
Licence(s) Held:
Registered Dealer of Pharmaceutical Ingredients, MedCan permit and EU-GDP Wholesaler. Medical Import Licence. EU-GMP manufacturing certification in progress.
100% Equity Sale. Price upon request.
Listing Details:
This is a fully operational, profitable medical cannabis importer & wholesaler with established distribution across the German market, the single largest and most valuable medical cannabis market in Europe.
The company is a solid revenue-generator, on target to reach €8 million in 2025, with €10.8 Million in revenue projected for 2026.
The platform provides direct, regulatory-compliant market access, leveraging established EU-GDP and EU-GMP supply chains and a trusted network of 40 global suppliers for broad-based product sourcing.
The company distributes a diverse product portfolio (+50 products across +35 strains), including its own proprietary brands.
The company is actively pending EU-GMP manufacturing certification which will provide a clear, de-risked pathway to internal processing and product manufacturing, allowing the capture of higher-margin activities.
The company is led by an experienced management team with deep roots in the German pharmaceutical and pharmacy markets.
The R&D pipeline focuses on high-value product innovation, including access to an innovative lozenge formulation and specialized oral administration solutions, securing a future competitive advantage.
The business is highly scalable, successfully managing high-volume sales (over 2.5 tonnes annually) with a minimal workforce (15 FTEs), ready for increased throughput upon capital injection.
The acquisition secures access to a patented purification technology, ensuring a proprietary, cost-efficient supply chain of pharmaceutical-grade, EU-GMP certified product starting in 2026.
This opportunity is ideal for Global Cannabis Operators, Healthcare/Pharma Players, and Investment Firms seeking immediate, de-risked entry and a high-growth platform within the regulated German and European medical cannabis markets.
42249812560
NEW CANNABIS BUSINESSES FOR SALE
See the latest cannabis business listings on the market including dispensaries, cultivation facilities, greenhouses, labs, and more. If you're looking to invest, acquire, or expand, these business opportunities provide the perfect starting point to grow your footprint in the cannabis industry.
45967461758
Leading online patient acquisition & retention platform: 20,000+ active patient ecosystem and full Canadian regulatory compliance
Purpose-built for high-efficiency patient acquisition and retention within the Canadian medical cannabis sector, this low-overhead, tech-enabled platform provides a high-margin gateway for LPs and healthcare practitioners seeking to scale their patient bases quickly. Designed with scalability in mind, the platform is poised to expand into adjacent care segments and international markets
45958479515
Profitable, GACP-Certified 3,500 ft² micro cultivator in Montreal, QC for $599k obo
Exceptional opportunity to acquire an operational, GACP-certified, 3,500 ft² licensed micro-cultivation located in a multi-unit industrial complex located in Montreal, QC, featuring significant profit potential